Welcome to our dedicated page for Aflac news (Ticker: AFL), a resource for investors and traders seeking the latest updates and insights on Aflac stock.
Aflac Incorporated (NYSE: AFL), a global leader in supplemental insurance, provides critical financial protection through innovative products in the U.S. and Japan. This news hub offers investors and stakeholders centralized access to verified corporate developments, strategic initiatives, and market updates.
Track official announcements, product launches, and leadership changes alongside analyses of Aflac's voluntary benefits expansion and technology partnerships. Our curated collection includes earnings reports, regulatory filings, and coverage of community-focused programs like pediatric cancer research support.
Discover updates on Aflac's core insurance offerings including accident, dental, and cancer coverage innovations. Stay informed about operational milestones in both the Japanese and American markets through primary-source documents and contextual reporting.
Bookmark this page for real-time updates on AFL's financial performance, dividend declarations, and industry leadership in supplemental health solutions. Verify all information through direct links to SEC filings and company-issued communications.
Aflac reveals the inspiring journey of Antawong Thompson, a district sales coordinator with nearly 20 years of experience. His story began in 2001 when he suffered a serious leg injury during a skateboarding accident. Thankfully, he had an Aflac accident policy through his wife, which covered their medical bills. This experience prompted him to join Aflac, where he now leads and mentors a team of agents. Antawong emphasizes trust and community engagement, actively participating in fundraising for local children's hospitals. In recognition of his contributions, he was honored as the Children's Hospital Ambassador of California South Coast.
Aflac continues its long-standing partnership with Children's National Hospital, emphasizing support for pediatric health, particularly in sickle cell disease. In 2022, Aflac donated $100,000 to enhance treatment and research for sickle cell disease, marking over 27 years of commitment and more than $165 million in donations towards child health initiatives.
Senior VP Brad Knox shared insights on advocating for children's health, encouraging community involvement through hands-on service, donations, and board membership in local organizations. Aflac's efforts aim to improve the vibrance of children's healthcare in the Washington, D.C. area and beyond.
Aflac Incorporated (NYSE: AFL) announced that Chairman and CEO Daniel P. Amos will present at the Bank of America Securities 2023 Financial Services Conference on February 14, 2023, at 9:40 a.m. ET. The presentation will be available via live webcast, and a replay will be accessible within 24 hours for one year. Aflac provides supplemental health insurance to over 50 million individuals across Japan and the U.S., being a leader in the sector. The company has received multiple accolades for its ethical practices and sustainability commitment. For more details, register for the webcast at the provided link.
Aflac reported its fourth quarter results for 2022, revealing total revenues of $4.0 billion, a decline from $5.4 billion in Q4 2021. Net earnings fell sharply to $185 million or $0.30 per share, down from $1.0 billion or $1.57 per share last year, largely due to foreign exchange-related investment losses totaling $521 million. Adjusted earnings were $806 million, while total investments decreased to $117.4 billion. Aflac Japan saw net earned premiums drop 22.9% in dollar terms, but new sales rose 11.4% in Q4. The board declared a dividend of $0.42 per share, marking the 40th consecutive year of dividend increases.
Aflac Incorporated (NYSE: AFL) has been recognized for its performance and commitment to gender equality, making it to Fortune's Most Admired Companies list for the 22nd time and Bloomberg's Gender Equality Index for the fourth consecutive year.
Aflac ranked No. 1 in the Insurance: Life and Health industry for Long-Term Investment Value and No. 2 in Quality of Management. The company shows strong diversity, with 47% of senior management being people of color or women. Since August 1990, Aflac's stock has surged from 95 cents to over $71, reflecting a total shareholder return exceeding 13,144% by the end of 2022. The recognition highlights Aflac's commitment to integrating social responsibility with business performance.
Aflac has launched a partnership to introduce roving robot technology for children's hospitals across South Carolina, allowing patients to explore the South Carolina Aquarium from their rooms. The program, currently piloted at MUSC Shawn Jenkins Children's Hospital, will expand to Prisma Health Children's Hospital. Patients can control the robot from their tablets, engaging in a unique virtual experience while interacting with aquarium educators. This initiative, supported by a generous gift from Aflac, aims to provide comfort and joy to hospitalized children, enhancing their well-being during challenging medical times.
Aflac Incorporated emphasizes the need for a strong company culture to attract and retain talent amid a labor shortage. The organization highlights five crucial strategies to enhance employee engagement and satisfaction:
- Offer competitive benefits and compensation.
- Maintain clear communication about company strategies.
- Provide flexibility in work location.
- Clarify career paths for employees.
- Ensure diversity at all organizational levels.
These strategies reflect Aflac's commitment to creating a supportive work environment, which is vital in today's market.
Aflac Incorporated (NYSE: AFL) will announce its fourth quarter 2022 financial results on February 1, 2023, after market closure. The release will include earnings materials and a video update from CFO Max Brodén. A conference call will follow on February 2, 2023, at 8:00 a.m. ET, featuring CEO Daniel P. Amos and COO Frederick J. Crawford, who will discuss the results and future outlook. Aflac is a leading provider of supplemental health insurance in the U.S. and is well-regarded for its commitment to sustainability and ethical practices.